Saturday 17 October 2026 Export BFLY’s income statement to Excel — free account

Butterfly Network, Inc.

Butterfly Network, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $97.6 million, up 19.0% from fiscal 2024. In the quarter to June 2026, revenue grew 39.5%, EPS grew 16.7% and free cash flow fell 113.9%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

7.25 0.60 −7.64%

Follow BFLY

Alert me

Market cap: $2.1B
P/E: 0.0×
Fwd P/E: −20.8×
Dividend yield: —
F-score: 3/9
Altman Z: 1.56
Beneish M: −3.30
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 13.07

Total sells 126.13

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	1	3	—	—	—	—	—	—	—	1	—	—
Sell	4	6	3	1	5	2	1	2	12	3	4	1

Insider Ownership 17.52%

Capital & Financial Ratios $m

Market Cap 2,130.00

Revenue 112.14

Net Income (74.85)

Free Cash Flow (28.04)

Net Debt (124.66)

Current Ratio 4.06

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E (20.80)

P/S ratio 16.94

P/B ratio 10.03

Past 5Y EPS Growth —

This Y EPS Growth 10.71%

Next Y EPS Growth 32.00%

Next Y revenue growth 24.78%

Next 5Y EPS Growth 75.96%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 79.66%

10-year low 10-year high

P/B against its own 10 years 87.45%

10-year low 10-year high

EV/Sales against its own 10 years 83.57%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	134	89	150	125
Receivables	13	21	27	35
Inventory	73	71	61	59
Other	3	6	2	2
	231	193	249	238

	2023	2024	2025	Q'26
Payables	5	4	5	4
ST’ Debt	—	—	—	—
Other	0	0	1	0
	44	48	65	59

Compound Annual Growth %

	10y	5y	3y
Sales	—	16.11%	9.97%
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	(15.55%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	27	33	—	—	—
’25	21	23	21	32	98
’24	18	21	21	22	82
’23	15	18	15	17	66
’22	16	19	20	19	73
’21	12	17	15	19	63
’20	9	12	10	16	46

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(14)	(16)	—	—	—
’25	(12)	(7)	(3)	9	(13)
’24	(21)	(10)	(8)	(3)	(42)
’23	(43)	(26)	(16)	(13)	(99)
’22	(54)	(44)	(42)	(29)	(169)
’21	(63)	(37)	(46)	(43)	(189)
’20	(20)	(20)	(22)	(21)	(82)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(15)	(17)	—	—	—
’25	(12)	(8)	(4)	8	(16)
’24	(22)	(11)	(8)	(4)	(44)
’23	(45)	(27)	(17)	(16)	(105)
’22	(59)	(51)	(47)	(31)	(187)
’22	—	—	—	—	(169)
’21	(65)	(37)	(48)	(47)	(197)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.05)	(0.05)	—	—	—
’25	(0.06)	(0.06)	(0.13)	(0.06)	(0.31)
’24	(0.10)	(0.07)	(0.08)	(0.08)	(0.34)
’23	(0.17)	(0.14)	(0.13)	(0.21)	(0.65)
’22	(0.22)	(0.18)	(0.27)	(0.17)	(0.84)
’21	(0.01)	(0.02)	(0.07)	(0.08)	(0.19)
’20	(4.07)	(3.85)	(15.20)	(3.74)	(27.90)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	9.34	6.01	2.17	0.76	0.67	1.32	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	22.96	29.13	8.72	3.22	3.78	4.98
People
People	Employees	—	—	—	—	260	463	330	225	190	220
	Revenue/emp, $m	—	—	—	0.00	0.18	0.14	0.22	0.29	0.43	0.44
Income, $m
Income, $m	Revenue	—	—	—	28	46	63	73	66	82	98
	Gross margin, %	—	—	—	(75.75)	(132.37)	27.26	53.77	25.58	59.51	46.85
	EBT	—	—	—	(100)	(163)	(32)	(169)	(134)	(73)	(77)
	EBT margin, %	—	—	—	(361.44)	(351.78)	(51.61)	(229.84)	(202.76)	(88.38)	(78.84)
	Net income	—	0	—	(100)	(163)	(32)	(169)	(134)	(72)	(77)
	Depreciation	—	—	—	1	1	2	6	11	10	8
Per share, $
Per share, $	Revenue	—	—	—	4.72	7.64	0.36	0.37	0.32	0.39	0.40
	Earnings	—	—	—	(17.08)	(27.90)	(0.19)	(0.84)	(0.65)	(0.34)	(0.31)
	Cash flow	—	—	—	(20.63)	(13.49)	(1.09)	(0.85)	(0.48)	(0.20)	(0.05)
	Capex	—	—	—	(0.77)	(0.39)	(0.05)	(0.09)	(0.03)	(0.01)	(0.01)
	Free cash flow	—	—	—	(21.39)	(13.88)	(1.13)	(0.94)	(0.51)	(0.21)	(0.06)
	Book value	—	—	—	0.00	(59.75)	2.58	1.63	1.07	0.80	0.79
	Shares, m	—	—	—	6	6	174	200	205	212	247
Valuation, ×
Valuation, ×	P/E	—	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	—	0.00	2.59	18.59	6.37	3.30	8.05	9.62
	P/B	—	—	—	11.95	0.00	2.60	1.44	0.99	3.91	4.79
	EV/Sales	—	—	—	0.00	2.46	12.69	3.87	2.08	7.62	8.63
	EV/FCF	—	—	—	0.00	(1.35)	(4.03)	(1.51)	(1.31)	(14.10)	(52.50)
Cash, $m
Cash, $m	Operating cash flow	—	—	—	(120)	(82)	(189)	(169)	(99)	(42)	(13)
	Capex	—	—	—	(4)	(2)	(8)	(18)	(6)	(3)	(3)
	Free cash flow	—	—	—	(125)	(84)	(197)	(187)	(105)	(44)	(16)
Balance, $m
Balance, $m	Working capital	—	—	—	—	28	462	306	187	144	184
	Total debt	—	—	—	—	54	28	30	—	—	—
	Net debt	—	—	—	—	(6)	(423)	(238)	(134)	(89)	(150)
	Shareholders’ equity	—	—	—	—	(362)	448	325	220	169	196
Returns, %
Returns, %	ROA	—	—	—	0.00	(110.57)	(9.01)	(34.10)	(37.04)	(25.87)	(27.89)
	ROIC	—	—	—	0.00	0.00	(484.73)	(137.79)	(106.30)	(58.09)	(118.73)
	ROE	—	—	—	0.00	44.97	(75.58)	(43.65)	(49.03)	(37.28)	(42.25)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
NEOG Neogen Corporation	$2.7B	— (loss-making)	— (loss-making)	+6.51% (above 0%: growing)	n/m	+135.75% (above 0%: growing)	47.35%	(0.81%)	Compare
TMDX TransMedics Group, Inc.	$2.7B	16.0×	34.1×	+20.70% (above 0%: growing)	−59.22% (below 0%: shrinking)	−87.62% (below 0%: shrinking)	59.59%	12.50%	Compare
UFPT UFP Technologies, Inc.	$2.3B	31.2×	23.6×	+15.07% (above 0%: growing)	+20.63% (above 0%: growing)	−35.77% (below 0%: shrinking)	29.27%	16.15%	Compare
BFLY Butterfly Network, Inc.	$2.1B	— (loss-making)	— (loss-making)	+39.47% (above 0%: growing)	n/m	−113.85% (below 0%: shrinking)	71.41%	(41.90%)
AXGN AxoGen, Inc.	$2.1B	— (loss-making)	— (loss-making)	+23.06% (above 0%: growing)	n/m	−17.36% (below 0%: shrinking)	72.67%	(3.09%)	Compare
INSP Inspire Medical Systems, Inc.	$2.0B	14.8×	93.5×	−7.60% (below 0%: shrinking)	n/m	+322.84% (above 0%: growing)	85.48%	(0.26%)	Compare
ESTA Establishment Labs Holdings Inc.	$1.8B	— (loss-making)	— (loss-making)	+31.66% (above 0%: growing)	n/m	+2.75% (above 0%: growing)	70.64%	(6.35%)	Compare
ATEC Alphatec Holdings, Inc.	$1.7B	— (loss-making)	— (loss-making)	+15.07% (above 0%: growing)	n/m	−146.87% (below 0%: shrinking)	72.17%	(0.89%)	Compare
NVCR NovoCure Limited	$1.7B	— (loss-making)	— (loss-making)	+15.60% (above 0%: growing)	n/m	+105.68% (above 0%: growing)	77.61%	(5.75%)	Compare
Median of peers	$2.1B	16.0×	34.1×	+15.34%	—	−7.30%	71.41%	(0.85%)

All 149 Medical Devices stocks →

Butterfly Network, Inc. (BFLY) key facts

Strength: Butterfly Network, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $97.6 million, up 19.0% from fiscal 2024.
Butterfly Network, Inc. (BFLY) is a Medical Devices company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, BFLY traded at $7.25, a market capitalization of $2.1 billion.
Return on equity was −42.3% and debt-to-equity 0.00.
Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 1.56 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.